“If evidence supports a better value for clinical and economic choices, and you throw those on a lower tier, that is to motivate member behavior towards the better value choices. Then, if the individual spends more money, it’s by choice, not need.”
—Tim Heady, CEO of UnitedHealth Pharmaceutical Solutions at UnitedHealth Group, quoted in “Fourth Tiers Could Generate Drug Savings or Increase Medical Spend,” which appears in the October 2010 issue of Specialty Pharmacy News.
